Reuters: insurers show easing medical costs

UnitedHealth Group, CVS Health, Humana and Cigna used first-quarter earnings to tell investors that medical-cost pressure looked more manageable than it did a year ago. The signal mattered because rising use of care in Medicare Advantage and Medicaid had battered the sector over the past three years, squeezing margins and forcing benefit cuts, pricing changes and tighter utilization controls. Reuters reported on May 13 that Wall Street analysts saw the quarter as encouraging but incomplete, with another quarter needed before they would call the trend durable. ### Which numbers changed enough to get investors’ attention? CVS Health reported on May 6 that its Health Care Benefits segment medical benefit ratio fell to 84.6% in the first quarter from 87.3% a year earlier, helping drive higher profit and a raised full-year outlook. The company said the improvement reflected continued execution on its margin recovery plan, though it kept what it called a cautious view for the rest of 2026 because cost trends remained elevated. (money.usnews.com) UnitedHealth said on April 21 that its first-quarter medical cost ratio was 83.9%, down 90 basis points from the first quarter of 2025. The company linked the result to pricing discipline, medical cost management and favorable reserve development in prepared remarks released with earnings. (cvshealth.com) Humana said on April 29 that its insurance segment benefit ratio was 89.4%, slightly better than management’s guidance of just under 90%. Cigna said on April 30 that its first-quarter medical care ratio was 79.8% and that results were helped in part by lower flu volumes and weather-related care deferrals. (unitedhealthgroup.com) ### Why are analysts refusing to call this a clean trend yet? Reuters reported that analysts wanted another quarter of similar results before concluding that medical-cost inflation had truly eased. The caution reflects how first-quarter claims arrive with a lag, leaving insurers with incomplete data when they report earnings. (policy.humana.com) Baird analyst Michael Ha told CNBC that investors should take first-quarter results “with a grain of salt” because by quarter-end insurers may only have hard claims data from January. CNBC also reported that second-quarter results are viewed as the more reliable test because hospital stays and procedures can take one to two months to be fully reviewed and reimbursed. (money.usnews.com) Barclays analyst Andrew Mok said, as cited by CNBC, that some of the stronger first-quarter showing was expected because of seasonal factors including a milder flu season and weather disruptions that temporarily suppressed medical costs. That distinction matters because a temporary drop in use is different from a lasting slowdown in underlying trend. ### Where is the pressure easing, and where is it still showing up? (cnbc.com) Elevance Health reported on April 22 that its first-quarter benefit expense ratio rose to 86.8%, up 40 basis points from a year earlier. The company said elevated medical cost trend in Medicaid remained a drag, though improved Medicare performance partly offset it. (europesays.com) Humana’s first-quarter release pointed to a business still managing high Medicare Advantage utilization even as results came in slightly favorable to plan. CVS likewise said it was maintaining caution for the rest of the year despite better first-quarter margins. Reuters said the recent improvement followed a period in which government-sponsored plans, especially Medicare Advantage and Medicaid, had driven much of the industry’s cost pressure. (elevancehealth.com) That means the easing signal is broad enough to matter, but uneven enough that investors are still parsing line by line which books of business improved and why. (policy.humana.com) ### What could change if the second quarter confirms the same pattern? Medical-cost ratios determine how much of every premium dollar insurers spend on care, so even modest improvements can quickly lift earnings. First-quarter beats helped several insurers raise or affirm 2026 guidance, including CVS, UnitedHealth, Cigna and Humana. (money.usnews.com) Analysts told Reuters that a sustained easing in costs could eventually affect how insurers design benefits and manage utilization. Reuters also said the industry is not there yet, because companies and investors still need a second quarter with similar claims experience before treating the first-quarter results as a durable reset. (investors.cvshealth.com) ### When will the next real readout arrive? Late July is the next scheduled checkpoint because that is when major managed-care companies typically report second-quarter earnings. UnitedHealth, Elevance, Humana and CVS used April and early May reports to describe first-quarter conditions, and their next updates will show whether January’s softer claims data carried into spring. (unitedhealthgroup.com) (money.usnews.com)